Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
19
Number of overlapping holdings
14.0%
% of XBI's 136 holdings also in FBT
63.3%
% of FBT's 31 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus FBT)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in FBT |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 3.5% | 4.3% | 3.5% |
|
GILEAD SCIENCES INC | 3.0% | 3.6% | 3.0% |
|
INCYTE CORP | 2.9% | 3.5% | 2.9% |
|
UNITED THERAPEUTICS CORP | 2.9% | 3.4% | 2.9% |
|
NEUROCRINE BIOSCIENCES INC | 2.8% | 3.7% | 2.8% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to FBT
|
ADVENTRX PHARMACEUTICALS INC | 2.8% |
|
INSMED INC | 2.6% |
|
ABBVIE INC | 2.4% |
|
MADRIGAL PHARMACEUTICALS, INC. | 2.2% |
|
VIKING THERAPEUTICS, INC. | 1.9% |
|
BLUEPRINT MEDICINES CORP. | 1.7% |
|
TG THERAPEUTICS INC | 1.7% |
|
CYTOKINETICS INC | 1.6% |
|
CRISPR THERAPEUTICS AG | 1.5% |
 |
ROIVANT SCIENCES LTD. | 1.2% |
XBI Underweight Relative to FBT
|
CORCEPT THERAPEUTICS INC | -4.1% |
 |
ARGENX SE ADR | -3.8% |
|
REPLIGEN CORP | -3.8% |
|
INTRA-CELLULAR THERAPIES INC | -3.7% |
|
WATERS CORP | -3.6% |
 |
BIONTECH SE SPONSORED ADR | -3.4% |
|
ILLUMINA INC | -3.3% |
|
EXELIXIS INC | -3.3% |
|
CATALYST PHARMACEUTICAL PART | -3.1% |
|
ACADIA PHARMACEUTICALS INC | -3.1% |